Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Standard
Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors. / L 'Estrade, Elina T; Shalgunov, Vladimir; Edgar, Fraser G; Strebl-Bantillo, Martin G; Xiong, Mengfei; Crestey, François; Neelamegam, Ramesh; Dyssegaard, Agnete; Lehel, Szabolcs; Erlandsson, Maria; Ohlsson, Tomas; Hooker, Jacob M; Knudsen, Gitte M; Herth, Matthias M; Hansen, Hanne D.
I: Journal of Labelled Compounds and Radiopharmaceuticals, Bind 63, 2020, s. 46-55.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors
AU - L 'Estrade, Elina T
AU - Shalgunov, Vladimir
AU - Edgar, Fraser G
AU - Strebl-Bantillo, Martin G
AU - Xiong, Mengfei
AU - Crestey, François
AU - Neelamegam, Ramesh
AU - Dyssegaard, Agnete
AU - Lehel, Szabolcs
AU - Erlandsson, Maria
AU - Ohlsson, Tomas
AU - Hooker, Jacob M
AU - Knudsen, Gitte M
AU - Herth, Matthias M
AU - Hansen, Hanne D
N1 - This article is protected by copyright. All rights reserved.
PY - 2020
Y1 - 2020
N2 - PURPOSE: The serotonin 7 (5-HT7 ) receptor is suggested to be involved in a broad variety of CNS disorders, but very few in vivo tools exist to study this important target. olecular imaging with positron emission tomography (PET) would enable an in vivo characterization of the 5-HT7 receptor. However, no clinical PET radiotracer exists for this receptor and thus we aimed to develop such a tracer. In this study, we present the preclinical evaluation of [11 C]Cimbi-701.PROCEDURES: Cimbi-701 was synthesized in a one-step procedure starting from SB-269970. Its selectivity profile was determined using an academic screening platform (NIMH Psychoactive Drug Screening Program). Successful radiolabeling of [11 C]Cimbi-701 and subsequent in vivo evaluation was conducted in rats, pigs and baboon. In vivo specificity was investigated by 5-HT7 and σ receptor blocking studies. P-gp efflux transporter dependency was investigated using elacridar.RESULTS: [11 C]Cimbi-701 could successfully be synthesized. Selectivity profiling revealed high affinity for the 5-HT7 (Ki = 18 nM), σ-1 (Ki = 9.2 nM) and σ-2 (Ki = 1.6 nM) receptors. In rats, [11 C]Cimbi-701 acted as a strong P-gp substrate. After P-gp inhibition, rat brain uptake could specifically be blocked by 5-HT7 and σ receptor ligands. In pig, high brain uptake and specific 5-HT7 and σ-receptor binding was found for [11 C]Cimbi-701 without P-gp inhibition. Finally, low brain uptake was found in baboons.CONCLUSIONS: Both the specific σ-receptor binding and the low brain uptake of [11 C]Cimbi-701 displayed in baboons, discouraged further translation to humans. Instead, we suggest exploration of this structural class, as results indicate that selective 5-HT7 receptor imaging might be possible when more selective non-P-gp substrates are identified.
AB - PURPOSE: The serotonin 7 (5-HT7 ) receptor is suggested to be involved in a broad variety of CNS disorders, but very few in vivo tools exist to study this important target. olecular imaging with positron emission tomography (PET) would enable an in vivo characterization of the 5-HT7 receptor. However, no clinical PET radiotracer exists for this receptor and thus we aimed to develop such a tracer. In this study, we present the preclinical evaluation of [11 C]Cimbi-701.PROCEDURES: Cimbi-701 was synthesized in a one-step procedure starting from SB-269970. Its selectivity profile was determined using an academic screening platform (NIMH Psychoactive Drug Screening Program). Successful radiolabeling of [11 C]Cimbi-701 and subsequent in vivo evaluation was conducted in rats, pigs and baboon. In vivo specificity was investigated by 5-HT7 and σ receptor blocking studies. P-gp efflux transporter dependency was investigated using elacridar.RESULTS: [11 C]Cimbi-701 could successfully be synthesized. Selectivity profiling revealed high affinity for the 5-HT7 (Ki = 18 nM), σ-1 (Ki = 9.2 nM) and σ-2 (Ki = 1.6 nM) receptors. In rats, [11 C]Cimbi-701 acted as a strong P-gp substrate. After P-gp inhibition, rat brain uptake could specifically be blocked by 5-HT7 and σ receptor ligands. In pig, high brain uptake and specific 5-HT7 and σ-receptor binding was found for [11 C]Cimbi-701 without P-gp inhibition. Finally, low brain uptake was found in baboons.CONCLUSIONS: Both the specific σ-receptor binding and the low brain uptake of [11 C]Cimbi-701 displayed in baboons, discouraged further translation to humans. Instead, we suggest exploration of this structural class, as results indicate that selective 5-HT7 receptor imaging might be possible when more selective non-P-gp substrates are identified.
U2 - 10.1002/jlcr.3808
DO - 10.1002/jlcr.3808
M3 - Journal article
C2 - 31674045
VL - 63
SP - 46
EP - 55
JO - Journal of Labelled Compounds and Radiopharmaceuticals
JF - Journal of Labelled Compounds and Radiopharmaceuticals
SN - 0362-4803
ER -
ID: 231253390